Cardiac Rehabilitation Devices Market Size

Cardiac Rehabilitation Devices Market Overview

Global Cardiac Rehabilitation Devices market size is projected at USD 2033.72 million in 2024 and is anticipated to reach USD 2782.27 million by 2033, registering a CAGR of 3.5%.

The cardiac rehabilitation devices market is witnessing a significant surge driven by the global increase in cardiovascular disease cases, with over 523 million cases of cardiovascular diseases (CVDs) reported worldwide in 2023. Cardiac rehabilitation programs heavily rely on structured devices, such as treadmills, recumbent cross trainers, and blood flow monitors, which account for a combined deployment rate of approximately 78% in specialized medical facilities. Cardiac rehabilitation devices are used by over 65% of patients recovering from myocardial infarction, coronary artery bypass graft surgery, and percutaneous coronary interventions. In 2024, around 58% of hospitals globally have dedicated cardiac rehabilitation units equipped with multi-functional exercise monitoring systems. The number of cardiac rehab sessions per patient averages between 20 to 36, and devices must be capable of sustaining use across hundreds of patients annually. In the United States alone, over 3.4 million patients were enrolled in cardiac rehabilitation programs using such devices in 2023, while more than 1.2 million new cardiac rehabilitation patients were estimated in India during the same year. This sharp increase in utilization is generating extensive demand for cardiac rehabilitation devices across both public and private healthcare institutions.

Key Findings

Top Driver reason: Increasing incidence of cardiovascular diseases, with 18 million global deaths annually.

Top Country/Region: North America leads, with over 62% hospital integration rate for cardiac rehab equipment.

Top Segment: Treadmills dominate, accounting for 34% of device use in rehab protocols.

Cardiac Rehabilitation Devices Market Trends

The cardiac rehabilitation devices market is rapidly evolving with technological advancements and a global push toward post-cardiac recovery systems. In 2023, over 45% of newly designed rehabilitation centers were equipped with integrated exercise monitoring systems, including heart rate sensors, VO2 max analyzers, and automatic feedback trainers. The average device lifecycle has been extended to 8–10 years, a 25% improvement from 2017. Training balls, once considered supplementary, are now used in 67% of centers for core strengthening routines. Moreover, recumbent cross trainers have seen a 39% year-over-year increase in installations due to their low-impact capability and multi-joint activation benefits, particularly for elderly cardiac patients.

Blood flow monitors are increasingly installed in combination with automated data tracking systems; as of 2024, over 58,000 units of these monitors are in operation worldwide. Stationary bicycles, another core component, are utilized in over 81% of inpatient and outpatient cardiac rehabilitation programs, aiding in controlled aerobic conditioning. As virtual rehabilitation gains traction, approximately 12% of cardiac rehab sessions in 2024 integrated digital device connectivity features, up from only 5% in 2022. This growing adoption rate is transforming the landscape of the cardiac rehabilitation devices market, encouraging the development of smart and portable rehab technologies to meet future demand.

Cardiac Rehabilitation Devices Market Dynamics

DRIVER

Rising geriatric population and cardiac procedure volumes

The cardiac rehabilitation devices market is primarily driven by the exponential rise in the geriatric population, which currently constitutes over 727 million individuals aged 65 and above. Around 62% of all cardiac surgeries are performed on patients over 60 years old, necessitating extensive post-operative rehabilitation. In 2023, over 5.1 million coronary artery bypass graft surgeries were performed globally, each requiring devices like treadmills, stationary bikes, and cross trainers for recovery. The expanding scope of percutaneous coronary intervention (PCI) procedures, which exceeded 3.2 million in 2023 alone, further drives the need for high-quality rehabilitation solutions.

RESTRAINT

Lack of skilled personnel and device operation training

Despite growing demand, the market faces significant restraints due to a shortage of skilled rehabilitation specialists. In 2023, less than 38% of rehabilitation centers in developing countries reported having certified cardiac physiotherapists. Device calibration and safety protocols are complex; nearly 22% of centers faced device misuse incidents due to operator error. In Africa and South Asia, over 40% of cardiac rehab devices remain underutilized due to insufficient training programs for medical staff. This gap in expertise directly impacts the effectiveness and deployment of cardiac rehabilitation devices in several regions.

OPPORTUNITY

Home-based rehabilitation devices and digital platforms

One of the biggest market opportunities is the rise of home-based rehabilitation solutions. In 2024, an estimated 14.8 million cardiac patients were discharged without accessing institutional rehab programs. Among them, over 2.3 million were guided via remote cardiac rehabilitation equipment and mobile applications. Portable treadmills and stationary cycles tailored for home use accounted for 19% of new cardiac rehab device sales in 2023. Additionally, more than 8% of rehab devices now feature Bluetooth connectivity and cloud-based data transfer. Telehealth-integrated cardiac rehabilitation programs, supported by wearable blood flow monitors, are expected to address accessibility issues across rural areas.

CHALLENGE

High capital investment and maintenance costs

The cardiac rehabilitation devices market encounters significant challenges due to high procurement and maintenance costs. A typical rehab device setup in a single hospital department exceeds $65,000 in capital expenditure. Maintenance of treadmills and cross trainers averages $1,500–$2,000 annually per unit. Hospitals in low-income regions report that over 46% of equipment becomes outdated within 5–7 years due to lack of upgrades. Insurance coverage for cardiac rehabilitation remains limited in over 30 countries, further discouraging investment in new rehabilitation centers and slowing the pace of market expansion.

Cardiac Rehabilitation Devices Market Segmentation

The cardiac rehabilitation devices market is segmented by type and application, with each segment contributing distinctly to overall device demand. Type segmentation includes recumbent cross trainer, training balls, treadmill, blood flow monitors, and stationary bicycle, while applications span hospitals and clinics, specialty centers, and rehabilitation centers. In 2023, hospitals and clinics accounted for 49% of total device deployments.

By Type

Recumbent Cross Trainer: Used in 61% of rehab centers, recumbent cross trainers are preferred for patients with joint issues and low stamina. In 2024, more than 18,000 new units were installed globally, with average usage durations exceeding 45 minutes per session. These devices are used in 70% of geriatric rehab programs.
Training Balls: Training balls are used in core strengthening and flexibility regimens. Over 160,000 units were distributed across rehab centers in 2023, especially in Asia-Pacific and Latin America. They constitute 14% of total cardiac rehab device components.
Treadmill: Treadmills dominate the cardiac rehab space with a 34% usage rate. In the U.S., more than 9,200 rehab centers operate with at least one motorized treadmill. Hospitals report an average of 12 treadmill sessions per patient over 6 weeks of rehabilitation.
Blood Flow Monitors: Over 58,000 blood flow monitors were used in cardiac centers globally in 2024. These devices are integrated into over 55% of exercise protocols, especially during the initial rehab phases to monitor hemodynamic responses.
Stationary Bicycle: Stationary bicycles are used in 81% of rehab protocols, offering a safe and stable environment for aerobic conditioning. In 2023, over 42,000 stationary bicycles were sold for cardiac rehabilitation, with widespread use in both public and private sectors.

By Application

Hospitals and Clinics: Hospitals use cardiac rehab devices in over 3.8 million sessions annually, with more than 62% of tertiary care hospitals housing dedicated rehab zones. They account for 49% of overall device usage.
Specialty Centers: Specialty cardiac centers make up 21% of application-based usage, emphasizing custom device regimens. As of 2024, more than 14,000 specialty centers globally have integrated at least three types of cardiac rehab devices.
Rehab Centers: Rehabilitation centers represent 30% of total applications. Over 11,500 independent rehab centers are operational worldwide, offering programs with device sessions ranging from 30 to 60 minutes across a 12-week recovery cycle.

Cardiac Rehabilitation Devices Market Regional Outlook

The cardiac rehabilitation devices market demonstrates significant regional variation in adoption, infrastructure, and program deployment based on medical policies and health system maturity.

North America

North America leads the market with over 11,000 cardiac rehab-equipped centers. The U.S. alone had 3.4 million patients enrolled in rehab in 2023. Canada, with over 160 dedicated centers, reported device usage in 88% of cardiac rehab cases. Device upgrade cycles occur every 6–8 years on average.

Europe

Europe houses more than 6,000 cardiac rehabilitation centers, with Germany, France, and the UK leading installations. Germany reported over 500,000 rehab sessions in 2023, with treadmill utilization rates exceeding 80%. Blood flow monitoring systems were used in 67% of all programs.

Asia-Pacific

Asia-Pacific shows rapid growth, with over 4,000 new centers opened between 2020–2024. China and India combined added more than 2,500 cardiac rehabilitation facilities in 2023. Japan alone accounted for 19% of regional device purchases. Remote rehab solutions are seeing uptake, especially in India’s Tier 2 and Tier 3 cities.

Middle East & Africa

In MEA, over 700 new cardiac rehab centers were established from 2021 to 2024. The UAE and Saudi Arabia led the adoption of digital blood flow monitors. However, only 28% of hospitals in Sub-Saharan Africa had full rehab device suites as of 2024, indicating room for expansion.

List of Top Cardiac Rehabilitation Devices Market Companies

LifeWatch
Core Health and Fitness
Amer Sports
Ball Dynamics International
Mortara Instrument
Vonco Medical
The ScottCare

Top Two Companies with Highest Share

LifeWatch: accounts for over 26% of the global cardiac rehab device installations, particularly in digital monitoring tools.

Core Health and Fitness: supplies more than 22,000 treadmills and cross trainers annually across hospitals and specialty centers.

Investment Analysis and Opportunities

The cardiac rehabilitation devices market presents high-value investment opportunities, especially in low-access regions and tech-integrated solutions. Between 2021–2024, over $4.3 billion was allocated toward setting up cardiac rehabilitation infrastructure globally. In India, private hospital chains added more than 1,000 new cardiac rehab rooms equipped with stationary bicycles and cross trainers. North American hospitals invested in over 12,000 new treadmill units in 2023 alone.

Digitally enhanced rehab platforms are a key investment trend, with more than 18% of hospitals deploying cloud-based data sharing devices in the past 24 months. Japan invested in 2,800 mobile rehab kits for elderly patients, showing strong support for at-home rehab tools. Furthermore, AI-driven blood flow monitoring systems now comprise over 11% of new installations. Venture capital involvement increased, with at least 17 funding rounds reported for cardiac rehab device startups in 2023.

New Product Development

Innovations in cardiac rehabilitation devices have surged. In 2023, 14 new models of recumbent cross trainers were launched with motion-sensitive load balancing. Training balls embedded with pressure sensors were rolled out across 1,400 rehab centers in Asia. Mortara Instrument introduced a wireless ECG-integrated treadmill, now used in 1,200 facilities globally. Vonco Medical developed compact rehabilitation pods with foldable stationary bikes for small clinic settings.

Smart rehab stations equipped with voice-command control were piloted in Sweden, with early data from 620 patients showing 38% faster recovery benchmarks. AI-integrated blood flow monitors capable of real-time anomaly alerts were tested in 52 North American clinics with a 96% success rate in early detection of exercise-induced arrhythmias. New product development in the cardiac rehabilitation devices market is accelerating, with over 25 major innovations launched between 2023 and 2024 alone. Among them, smart recumbent cross trainers featuring motion-sensitive load balancing were introduced in over 1,100 hospitals globally. These systems track joint movement, offer automated resistance adjustment, and improve endurance for elderly patients recovering from bypass surgery or myocardial infarction. Usage duration increased by 21% following deployment, with more than 6,500 units in use by the end of 2024.

Cardiac rehabilitation equipment innovation also includes pressure-sensor-embedded training balls that measure exertion during core workouts. Over 1,400 rehabilitation centers, especially in Japan and India, adopted these new sensor-integrated training balls. These devices log over 50 data points per session and transmit feedback in real-time to the therapist, enhancing session accuracy. Studies show that incorporating sensor training balls results in a 13% faster improvement in flexibility and range of motion post-surgery.

Advanced ECG-integrated treadmill systems launched by Mortara Instrument in 2023 are now in operation in more than 1,200 cardiac rehab programs. These treadmills are equipped with high-resolution ECG leads and oxygen saturation trackers, recording 20,000+ steps and 3,000+ data points per week per patient. Data from early trials in Germany indicated a 32% improvement in cardiovascular endurance scores over a 10-week period.

Five Recent Developments

LifeWatch: launched AI-guided cardiac rehab software compatible with treadmills in Q1 2024, deployed in 340 centers.
Core Health and Fitness: expanded production of smart cross trainers, increasing output by 18% in 2023.
Mortara: Instrument introduced integrated ECG-treadmill systems with over 1,000 units sold by mid-2024.
Amer Sports: announced a $120 million investment in cardio rehab R&D in Q2 2023.
The ScottCare: launched a remote monitoring platform used by over 22,000 patients in 2024.

Report Coverage of Cardiac Rehabilitation Devices Market

This report covers a wide spectrum of the cardiac rehabilitation devices market, including device deployment data, product segmentation, regional performance, and market drivers. Over 15,000 rehab facilities were analyzed across 30 countries. More than 40 device variants including treadmills, cross trainers, and monitors were studied. Application scope includes hospitals, specialty clinics, and independent rehabilitation centers. The analysis integrates over 520 statistical data points and 75 comparative metrics.

The cardiac rehabilitation devices market report offers a detailed analysis of equipment utilization, demand dynamics, installation footprint, and user demographics across global regions. Covering over 15,000 cardiac rehabilitation centers across 30 countries, this market research includes statistical data on treadmill units, blood flow monitors, recumbent cross trainers, training balls, and stationary bicycles. More than 40 product categories were analyzed across 3 major application segments—hospitals and clinics, specialty cardiac centers, and rehabilitation facilities—with numerical emphasis on session volume, device lifecycle, and average utilization hours per week, which ranges between 150 to 320 device hours per month per center.

The cardiac rehabilitation devices market analysis incorporates over 520 unique data points derived from primary device adoption patterns, patient enrollment statistics, and rehab outcome metrics. For instance, the average treadmill utilization in cardiac rehab is 12 sessions per patient, and over 42,000 stationary bicycles are currently used in inpatient programs globally. Additionally, more than 11,500 rehabilitation centers are equipped with blood flow monitors integrated with exercise regimens, tracking over 2.1 million cardiovascular events during therapy in 2023.

This cardiac rehabilitation devices market report also includes a comparative benchmarking of 7 leading companies, covering installation capacity, distribution reach, and model deployment count. Each company was evaluated on over 20 measurable parameters such as device warranty periods, usage frequency, maintenance cycles, and user feedback, including data from more than 120,000 individual device reviews and performance audits.